Kunjin replicon-based simian immunodeficiency virus gag vaccines

Area of Science:

• Virology and Immunology
• Vaccine Development
• RNA-based Vector Systems

Background:

• RNA-based replicon vector systems, derived from flaviviruses like Kunjin, offer potential for novel vaccine delivery.
• Simian immunodeficiency virus (SIV) gag vaccines are being explored for their potential in developing effective immunotherapies.

Purpose of the Study:

• To evaluate the efficacy of four distinct SIVmac239 gag vaccines delivered via Kunjin replicon virus-like particles in a murine model.
• To compare the immunogenicity, protective capacity, and insert stability of vaccines encoding wild-type gag, RNA-optimized gag, codon-optimized gag, and a modified gag-pol gene.

Main Methods:

• Development and application of Kunjin replicon virus-like particles for vaccine delivery.
• Construction of four SIVmac239 gag vaccine variants with differing RNA sequences (wild-type, RNA-optimized, codon-optimized, gag-pol).
• Assessment of immune responses (effector and central memory), protection, and insert stability in mice post-vaccination.

Main Results:

• Significant differences were observed in the induction of immune memory responses among the four vaccine constructs.
• Vaccine performance in mediating protection against SIV varied considerably based on the encoded gag gene sequence.
• The SIV gag-pol vaccine construct exhibited superior performance in terms of immune response, protection, and insert stability.

Conclusions:

• The sequence of the antigen's RNA within an RNA-based vector system can profoundly influence vaccine behavior and efficacy.
• Optimization of RNA sequences is critical for maximizing the performance of RNA-based vaccine delivery systems.
• The SIV gag-pol construct represents a promising candidate for further development as an RNA-based vaccine.